BIBW 2992 - Afatinib

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1544

CAS [850140-72-6]

MF C24H25ClFN5O3
MW 485.94

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

BIBW 2992

Description

Second generation tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal receptor 2 (Her2 or ErbB 2) and EGFR (HER1) kinases. An investigational drug for breast cancer as well as other EGFR and Her2 driven cancers such as NSCLC and Head-and-Neck

KEYWORDS: BIBW 2992 | supplier | EGFR/HER2 inhibitor | 850140-72-6 | 439081-18-2 | Afatinib | BIBW2992 | BIBW-2992 | EGFR | ErbB2-HER2 | TKI | breast cancer | epidermal | growft factor

Order
Size Unit Price Stock
2 mg €65.00 In Stock
5 mg €85.00 In Stock
25 mg €255.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €130.00 In Stock
2 x 25 mg €400.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...